Growth differentiation factor 15
This marker has no established reference range in dogs or cats yet, so it is read as a trend rather than measured against a threshold.
GDF-15 is a stress signal released by cells under strain, and in humans it is one of the strongest single-marker predictors of frailty and mortality. It is measurable in dogs and rises in preclinical heart disease — but there is no established canine or feline reference range, so it is read as a direction of travel, never judged against a threshold.
GDF-15 (growth differentiation factor 15) is a signal released by cells experiencing stress — from inflammation, low oxygen, metabolic strain, or ageing itself. Because so many tissues release it under duress, it behaves less like an organ-specific marker and more like a general barometer of how hard the body is working to hold itself together. In human medicine that broad quality has made it remarkable: GDF-15 is among the strongest single-marker predictors of frailty, functional decline and mortality across populations.

That is precisely why it interests a longevity-oriented practice, and precisely why it must be handled carefully here.
GDF-15 sits in the library's frontier layer at its most cautious end — "experimental". It is measurable in dogs, and research shows it rises in preclinical cardiac disease, but there is no established canine or feline reference interval. Without a validated band, there is no honest way to call a given value "high" or "normal" for a dog or cat. So on this platform GDF-15 is:
Presenting it any other way would fabricate a precision the science does not yet support.
Read purely as a direction, a rising GDF-15 is consistent with increasing systemic stress — cardiac strain, inflammation, or the broader burden that accompanies ageing. In research settings it has shown promise as an early signal in heart disease before clinical signs appear. But "consistent with" is doing important work in that sentence: because the signal is so non-specific, a rise cannot say which stress is responsible, and in an individual pet it is not a basis for action on its own. Its role is to add texture to a longitudinal picture built from validated markers.
A stable GDF-15 across serial measurements is, in the broadest sense, unremarkable — and a falling trend would be consistent with reduced systemic stress. Again, neither observation carries diagnostic weight in dogs or cats today. The honest position is that we are watching a line, not reading a verdict.
The evidence base is fuller in dogs, where GDF-15 has been measured and studied in cardiac disease; feline data are sparser. Neither species has a routine clinical reference interval, so the same trend-only treatment applies to both. If validated intervals emerge, this page — and the marker's treatment in the product — will be updated to match.
GDF-15 is measured from a blood sample by research or specialist assays, reported in pg/mL. Because methods differ between laboratories and no universal band exists, only measurements from the same assay should be compared over time. Any result should be interpreted with your veterinary surgeon and understood as an emerging research marker, not a clinical test.
The constructive use of GDF-15 today is curiosity, not action: it is a marker to watch over time alongside validated ones, and a signal of where veterinary longevity medicine may be heading. No treatment decision should rest on it, and a raised value is not a reason for alarm. If you and your vet choose to track it, do so on one laboratory's assay and read it as a trend within the fuller picture.
This page is educational and is not a diagnosis. Lab results are interpreted in the full clinical context by your veterinary surgeon; a single value rarely tells the whole story.